Ching‐Tien Peng

652 total citations
24 papers, 479 citations indexed

About

Ching‐Tien Peng is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Ching‐Tien Peng has authored 24 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Molecular Biology and 5 papers in Genetics. Recurrent topics in Ching‐Tien Peng's work include Parvovirus B19 Infection Studies (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Ching‐Tien Peng is often cited by papers focused on Parvovirus B19 Infection Studies (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Hemoglobinopathies and Related Disorders (3 papers). Ching‐Tien Peng collaborates with scholars based in Taiwan, United States and Belgium. Ching‐Tien Peng's co-authors include Wan‐Yu Lo, Huang-Joe Wang, Yuan‐Li Huang, Cheng‐Chieh Lin, Po‐Chao Huang, Wenkai Yang, Huey‐June Wu, Chang-Qing Li, Jinyi Wu and Kang‐Hsi Wu and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Infectious Diseases.

In The Last Decade

Ching‐Tien Peng

24 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ching‐Tien Peng Taiwan 11 147 94 91 73 66 24 479
Stephanie Tung Canada 10 120 0.8× 55 0.6× 69 0.8× 31 0.4× 59 0.9× 15 391
Qin Xie China 16 223 1.5× 106 1.1× 126 1.4× 34 0.5× 35 0.5× 42 763
Lananh Nguyen United States 11 164 1.1× 171 1.8× 82 0.9× 178 2.4× 32 0.5× 30 828
Kanehisa Morimoto Japan 13 167 1.1× 43 0.5× 110 1.2× 63 0.9× 15 0.2× 30 534
Denise Lowe United States 14 100 0.7× 62 0.7× 26 0.3× 54 0.7× 45 0.7× 26 485
Éva Kovács Hungary 15 257 1.7× 234 2.5× 133 1.5× 44 0.6× 17 0.3× 37 815
Lorenzo Caruso Italy 11 111 0.8× 35 0.4× 40 0.4× 22 0.3× 99 1.5× 41 428
Keith Borg United States 15 281 1.9× 110 1.2× 50 0.5× 95 1.3× 15 0.2× 31 617
Nicholas A. Vernice United States 10 149 1.0× 49 0.5× 34 0.4× 30 0.4× 19 0.3× 28 494
Ramon Bossardi Ramos United States 14 125 0.9× 100 1.1× 21 0.2× 50 0.7× 14 0.2× 36 589

Countries citing papers authored by Ching‐Tien Peng

Since Specialization
Citations

This map shows the geographic impact of Ching‐Tien Peng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ching‐Tien Peng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ching‐Tien Peng more than expected).

Fields of papers citing papers by Ching‐Tien Peng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ching‐Tien Peng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ching‐Tien Peng. The network helps show where Ching‐Tien Peng may publish in the future.

Co-authorship network of co-authors of Ching‐Tien Peng

This figure shows the co-authorship network connecting the top 25 collaborators of Ching‐Tien Peng. A scholar is included among the top collaborators of Ching‐Tien Peng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ching‐Tien Peng. Ching‐Tien Peng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ho, Mu‐Hsing, Ching‐Tien Peng, Yung Liao, & Hsin‐Yen Yen. (2024). Efficacy of a Wearable Activity Tracker With Step-by-Step Goal-Setting on Older Adults’ Physical Activity and Sarcopenia Indicators: Clustered Trial. Journal of Medical Internet Research. 26. e60183–e60183. 3 indexed citations
2.
Lin, Yen‐Chung, Jen‐Wei Chou, An‐Chyi Chen, et al.. (2022). Endoloop-Assisted Polypectomy for a Symptomatic Giant Colonic Polyp in a Pediatric Patient. Children. 9(2). 222–222. 3 indexed citations
3.
Lo, Wan‐Yu, et al.. (2018). MicroRNA-200a/200b Modulate High Glucose-Induced Endothelial Inflammation by Targeting O-linked N-Acetylglucosamine Transferase Expression. Frontiers in Physiology. 9. 355–355. 44 indexed citations
4.
5.
Lo, Wan‐Yu, Ching‐Tien Peng, & Huang-Joe Wang. (2017). MicroRNA-146a-5p Mediates High Glucose-Induced Endothelial Inflammation via Targeting Interleukin-1 Receptor-Associated Kinase 1 Expression. Frontiers in Physiology. 8. 551–551. 52 indexed citations
6.
Peng, Ching‐Tien, et al.. (2016). Safe needling depths of upper back acupoints in children: a retrospective study. BMC Complementary and Alternative Medicine. 16(1). 85–85. 6 indexed citations
7.
Li, Meng‐Ju, Yung‐Li Yang, Ni‐Chung Lee, et al.. (2015). Tet oncogene family member 2 gene alterations in childhood acute myeloid leukemia. Journal of the Formosan Medical Association. 115(9). 801–806. 10 indexed citations
8.
Wang, Huang-Joe, et al.. (2014). MicroRNA-146a Decreases High Glucose/Thrombin-Induced Endothelial Inflammation by Inhibiting NAPDH Oxidase 4 Expression. Mediators of Inflammation. 2014. 1–12. 77 indexed citations
9.
Chen, William Tzu‐Liang, Ching‐Tien Peng, Rouh‐Mei Hu, et al.. (2014). Association Between Genetic Polymorphism of the MIF Gene and Colorectal Cancer in Taiwan. Journal of Clinical Laboratory Analysis. 29(4). 268–274. 11 indexed citations
10.
Peng, Ching‐Tien, et al.. (2014). High Glucose/Thrombin-Induced Endothelial Inflammation Via Microrna-146a and Nox4 Regulation. Blood. 124(21). 5952–5952. 1 indexed citations
11.
Langley, Joanne M., Archana Chatterjee, Scott A. Halperin, et al.. (2013). Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Candidate: A Phase III Randomized Controlled Trial in Children. The Journal of Infectious Diseases. 208(4). 544–553. 51 indexed citations
12.
Li, Meng‐Ju, Yung‐Li Yang, Shiann‐Tarng Jou, et al.. (2011). Prevalence & Prognosis Value of TET2 Gene Polymorphisms in Childhood Acute Myeloid Leukemia in Taiwan. Blood. 118(21). 1551–1551. 2 indexed citations
13.
Lin, Chien‐Heng, et al.. (2010). Langerhans Cell Histiocytosis With Thyroid and Lung Involvement in a Child: A Case Report. Journal of Pediatric Hematology/Oncology. 32(4). 309–311. 6 indexed citations
14.
Chen, Chao-Hsien, et al.. (2010). Prevalence of human herpesvirus 8 DNA in peripheral blood mononuclear cells of acute and chronic leukemia patients in Taiwan: Table 1. FEMS Immunology & Medical Microbiology. 61(3). 356–358. 3 indexed citations
15.
16.
Peng, Ching‐Tien, I‐Ching Chou, Chia‐Ing Li, et al.. (2004). Association of the nicotinic receptor beta 2 subunit and febrile seizures. Pediatric Neurology. 30(3). 186–189. 10 indexed citations
17.
Chou, I‐Ching, et al.. (2003). The lack of association between febrile convulsions and polymorphisms in SCN1A. Epilepsy Research. 54(1). 53–57. 20 indexed citations
18.
Lin, Cheng‐Chieh, Ching‐Tien Peng, Chang-Qing Li, et al.. (2002). Approaching healthy body mass index norms for children and adolescents from health‐related physical fitness. Obesity Reviews. 3(3). 225–232. 68 indexed citations
19.
Peng, Ching‐Tien, Kuan‐Chih Chow, Su‐Peng Yeh, et al.. (2000). "Virus Infection in Pediatric Patients With Congenital Anemia in Taiwan: Detection of Erythrovirus B19, Epstein-Barr Virus and Cytomegalovirus. 5(4). 207–215. 3 indexed citations
20.
Peng, Ching‐Tien, et al.. (1999). Expression of Fas ligand in Langerhans' cell histiocytosis: A case report of a boy with multisystem involvement. American Journal of Hematology. 61(4). 256–261. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stephanie Tung Breakdown of academic impact, for papers by Qin Xie Breakdown of academic impact, for papers by Lananh Nguyen Breakdown of academic impact, for papers by Kanehisa Morimoto Breakdown of academic impact, for papers by Denise Lowe Breakdown of academic impact, for papers by Éva Kovács Breakdown of academic impact, for papers by Lorenzo Caruso Breakdown of academic impact, for papers by Keith Borg Breakdown of academic impact, for papers by Nicholas A. Vernice Breakdown of academic impact, for papers by Ramon Bossardi Ramos
Rankless by CCL
2026